The details of the PIONEER program, including study design and results, have been published and reviewed extensively, therefore only a brief overview is provided here [38, 39, 61, 62, 76,77,78,79,80,81,82]
The expiration date is printed on the box and vial
Globalement, les plaintes gastro-intestinales avec le smaglutide surviennent principalement dans les 8 12 premires semaines du traitement lors de laugmentation des doses contrairement au liraglutide, o elles surviennent en ~2 semaines puis sattnuent avec le temps
when GSH is taken orally, it has low bioavailability and is easily broken down by the stomach and is not effective